Good morning my name is shaik rahimunnisa and im from Kakinada and I
completed my mpharmacy in jntuk in cology specialization and I am
working as a Clinical Data Analyst with having experience in data analysis
and management and specialize in conducting comprehensive clinical and
biological data analysis to generate insightful reports from diverse
sources, including clinical trial documents, journals, and patents.
My responsibilities involve analyzing data related to drugs, drug targets,
as well as performing literature searches on clinical data and scientific
information.
Prior to my current role, I served as a Clinical Data Analyst (Junior
Executive) at Straive In this capacity, I gained hands-on experience in
analyzing, collecting, and entering clinical and preclinical data from
journals, patents, and research articles into databases.
A clinical trial is a research study conducted to evaluate the safety and
efficacy of medical interventions, such as new drugs, devices, or
treatments, in human subjects. Clinical trials are crucial for advancing
medical knowledge and improving patient care. These trials follow a
structured process, typically divided into phases, to systematically assess
the intervention's effectiveness and safety.
Here's an overview of the phases of a clinical trial:
1. Phase 1:
Objective: Assess safety and dosage.
Participants: A small group of healthy volunteers.
Focus: Establish the initial safety profile, dosage range, and
potential side effects.
2. Phase 2:
Objective: Evaluate efficacy and further assess safety.
Participants: Expanded to include a larger group of
individuals with the target condition.
Focus: Preliminary assessment of the intervention's
effectiveness, optimal dosage, and ongoing safety evaluation.
3. Phase 3:
Objective: Confirm efficacy, monitor side effects, and
compare to existing treatments.
Participants: Large and diverse patient populations.
Focus: Gather more comprehensive data on the
intervention's effectiveness, safety, and potential side effects.
Results help support regulatory approval.
4. Phase 4 (Post-Marketing Surveillance):
Objective: Monitor long-term safety and effectiveness after
regulatory approval.
Participants: Individuals who receive the approved
treatment.
Focus: Continuously assess the intervention's real-world
performance, identify rare side effects, and optimize usage.
Strengths: Answer: A key strength of mine is effective time management. I
excel in prioritizing tasks, setting realistic deadlines, and organizing my work
efficiently. This has allowed me to consistently meet project timelines and deliver
high-quality results
I sometimes find it challenging to delegate tasks because I like to ensure
everything is done to my standards. However, I'm actively working on improving
my delegation skills to foster better teamwork and efficiency within the projects
I'm involved in.
